首页> 外文期刊>Npj - Primary Care Respiratory Medicine >Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study
【24h】

Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study

机译:峰值流量计,带有问卷和微型肺活量计,有助于在现实生活中实践中检测哮喘和COPD:一项横断面研究

获取原文
           

摘要

Peak flow meter with questionnaire and mini-spirometer are considered as alternative tools to spirometry for screening of asthma and chronic obstructive pulmonary disease. However, the accuracy of these tools together, in clinical settings for disease diagnosis, has not been studied. Two hundred consecutive patients with respiratory complaints answered a short symptom questionnaire and performed peak expiratory flow measurements, standard spirometry with Koko spirometer and mini-spirometry (COPD-6). Spirometry was repeated after bronchodilation. Physician made a final diagnosis of asthma, chronic obstructive pulmonary disease and others. One eighty nine patients (78 females) with age 51鈥壜扁€?7 years with asthma (115), chronic obstructive pulmonary disease (33) and others (41) completed the study. 鈥淏reathlessness鈥?鈥?months鈥?and 鈥渃ough鈥?鈥?months鈥?were important symptoms to detect obstructive airways disease. 鈥淎symptomatic period鈥?鈥? weeks鈥?had the best sensitivity (Sn) and specificity (Sp) to differentiate asthma and chronic obstructive pulmonary disease. A peak expiratory flow of鈥?鈥?0% predicted was the best cut-off to detect airflow limitation (Sn 90%, Sp 50%). Respiratory symptoms with PEF鈥?鈥?0% predicted, had Sn 84 and Sp 93% to detect OAD. COPD-6 device under-estimated FEV1 by 13鈥塵L (95% CI: 鈭?12, 185). At a cut-off of 0.75, the FEV1/FEV6 had the best accuracy (Sn 80%, Sp 86%) to detect airflow limitation. Peak flow meter with few symptom questions can be effectively used in clinical practice for objective detection of asthma and chronic obstructive pulmonary disease, in the absence of good quality spirometry. Mini-spirometers are useful in detection of obstructive airways diseases but FEV1 measured is inaccurate.
机译:带有问卷和微型肺活量计的峰值流量计被认为是肺活量测定法的替代工具,用于筛查哮喘和慢性阻塞性肺疾病。但是,尚未对这些工具在疾病诊断的临床环境中的准确性进行研究。连续200例有呼吸道不适的患者回答了简短的症状问卷,并进行了峰值呼气流量测量,带Koko肺活量计的标准肺活量测定和小型肺活量测定(COPD-6)。支气管扩张后重复肺功能测定。医生对哮喘,慢性阻塞性肺疾病和其他疾病做出了最终诊断。 189名年龄在51岁以下7岁以下的哮喘患者(78名女性)患有哮喘(115),慢性阻塞性肺疾病(33)和其他患者(41)完成了研究。 “无气”,“月”和“通”月是检测阻塞性气道疾病的重要症状。 “症状期”?周来区分哮喘和慢性阻塞性肺疾病的最佳敏感性(Sn)和特异性(Sp)。预测的最大呼气流量“?”-?0%是检测气流限制的最佳截止点(Sn 90%,Sp 50%)。预测有PEF≤0%的呼吸道症状,Sn 84和Sp 93%可检测出OAD。 COPD-6装置将FEV1低估了13'尘升(95%CI:φ12,185)。极限值为0.75时,FEV1 / FEV6具有检测气流限制的最佳精度(Sn 80%,Sp 86%)。在没有高质量肺活量测定的情况下,几乎没有症状问题的峰值流量计可以有效地用于临床实践中,以客观检测哮喘和慢性阻塞性肺疾病。微型肺活量计可用于检测阻塞性气道疾病,但测量的FEV1不准确。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号